S25Q50C PARTNR2-METHOD 3-W2
Add Health
Wave II In-Home Interview
Wave II In-Home Interview
Wave II In-Home Interview
(1637 of 2539)
Variable Description
Name
H2RX50C2
Label
S25Q50C PARTNR2-METHOD 3-W2
Dataset
Summary Statistics for 'H2RX50C2'
| Value | Valid | Label | Frequency | % of Valid | % of All |
|---|---|---|---|---|---|
| . | Missing | missing | 8 |
0.05%
|
|
| 2 | Valid | withdrawal | 1 |
7.14%
|
0.01%
|
| 4 | Valid | birth control pills | 4 |
28.57%
|
0.03%
|
| 14 | Valid | no other method | 9 |
64.29%
|
0.06%
|
| 97 | Missing | legitimate skip | 14,716 |
99.85%
|
| Total Responses | Valid | Invalid | Min | Max |
|---|---|---|---|---|
| 14738 | 14 | 14724 | 2 | 14 |
Representation
Representation Type
Code List
Selection Style
SelectOne
Measurement Unit
numeric
withdrawal, birth control pills, no other method
withdrawalMeasurement Unit
numeric
Aggregation Method
Unspecified
Temporal
False
Geographic
False
Represented Variable
Non-Relationship, Romantic Partner: What other method of birth control did you or your partner use? (if intercourse has occurred over several months, third response, partner 2)Missing Values
legitimate skip, missingSource Questions
H2RX50C2Lineage
-
Wave II In-Home Interview -
H2RX50C2
S25Q50C PARTNR2-METHOD 3-W2-
50C2. 2nd RX Partner: What other method of birth control did you or your partner use?
-
Concordance
| Add Health | ||||
|---|---|---|---|---|
| Wave I | Wave II | |||
| Wave I In-Home Interview | Wave II In-Home Interview | |||
| Wave I In-Home Interview Data | Wave II In-Home Interview | |||
| H1RX38C2 | H2RX50C2 | |||
| withdrawal |
5.26%
|
7.14%
|
||
| rhythm (safe time) |
13.16%
|
|||
| birth control pills |
18.42%
|
28.57%
|
||
| vaginal sponge |
5.26%
|
|||
| diaphragm, with or without jelly |
2.63%
|
|||
| Norplant |
2.63%
|
|||
| some other method |
2.63%
|
|||
| no other method |
50.00%
|
64.29%
|
||
| Add Health | ||||
|---|---|---|---|---|
| Wave I | Wave II | |||
| Wave I In-Home Interview | Wave II In-Home Interview | |||
| Wave I In-Home Interview Data | Wave II In-Home Interview | |||
| H1RX38C2 | H2RX50C2 | |||
| withdrawal |
0.01%
|
0.01%
|
||
| rhythm (safe time) |
0.02%
|
|||
| birth control pills |
0.03%
|
0.03%
|
||
| vaginal sponge |
0.01%
|
|||
| diaphragm, with or without jelly |
0.00%
|
|||
| Norplant |
0.00%
|
|||
| some other method |
0.00%
|
|||
| no other method |
0.09%
|
0.06%
|
||
| Dataset | Variable | Valid | Invalid | Min | First Quartile | Median | Third Quartile | Max | Mean | StdDev |
|---|---|---|---|---|---|---|---|---|---|---|
| Wave I In-Home Interview Data | H1RX38C2 | 38 | 20,707 | 2 | 14 | |||||
| Wave II In-Home Interview | H2RX50C2 | 14 | 14,724 | 2 | 14 |
| Add Health | ||||
|---|---|---|---|---|
| Wave I | Wave II | |||
| Wave I In-Home Interview | Wave II In-Home Interview | |||
| Wave I In-Home Interview Data | Wave II In-Home Interview | |||
| H1RX38C2 | H2RX50C2 | |||
| withdrawal | 2 | 2 | ||
| rhythm (safe time) | 3 | |||
| birth control pills | 4 | 4 | ||
| vaginal sponge | 5 | |||
| diaphragm, with or without jelly | 7 | |||
| Norplant | 9 | |||
| some other method | 13 | |||
| no other method | 14 | 14 | ||